{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:25:24Z","timestamp":1782152724625,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s11934-006-0061-6","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T10:46:09Z","timestamp":1181213169000},"page":"497-502","source":"Crossref","is-referenced-by-count":52,"title":["Priapism: New concepts in the pathophysiology and new treatment strategies"],"prefix":"10.1007","volume":"7","author":[{"given":"Trinity J.","family":"Bivalacqua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-5347(17)45549-2","volume":"135","author":"MA Spycher","year":"1986","unstructured":"Spycher MA, Hauri D: The ultrastructure of the erectile tissue in priapism. J Urol 1986, 135:142\u2013147.","journal-title":"J Urol"},{"issue":"Suppl 4","key":"61_CR2","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1038\/sj.ijir.3900592","volume":"12","author":"A Melman","year":"2000","unstructured":"Melman A, Serels S: Priapism. Int J Impot Res 2000, 12(Suppl 4):S133-S139.","journal-title":"Int J Impot Res"},{"key":"61_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.ju.0000046303.22757.f2","volume":"170","author":"AL Burnett","year":"2003","unstructured":"Burnett AL: Pathophysiology of priapism: dysregulatory erection physiology thesis. J Urol 2003, 170:26\u201334.","journal-title":"J Urol"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/S1677-55382003000500002","volume":"29","author":"C Van Der Horst","year":"2003","unstructured":"Van Der Horst C, Stuebinger H, Seif C, et al.: Priapism-etiology, pathophysiology and management. Int Braz J Urol 2003, 29:391\u2013400.","journal-title":"Int Braz J Urol"},{"issue":"Suppl 5","key":"61_CR5","first-page":"S39","volume":"13","author":"R Berger","year":"2001","unstructured":"Berger R, Billups K, Brock G, et al.: Report of the American Foundation for Urologic Disease (AFUD) thought leader panel for evaluation and treatment of priapism. Int J Impot Res 2001, 13(Suppl 5):S39-S43.","journal-title":"Int J Impot Res"},{"key":"61_CR6","first-page":"9","volume":"6","author":"GA Broderick","year":"1994","unstructured":"Broderick GA, Harkaway R: Pharmacologic erection: timedependent changes in corporal environment. Int J Impot Res 1994, 6:9\u201316.","journal-title":"Int J Impot Res"},{"key":"61_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/00365599509180545","volume":"29","author":"R Kulmala","year":"1995","unstructured":"Kulmala R, Lehtonen T, Tammela TL: Priapism, its incidence and seasonal disturbances in Finland. Scand J Urol Nephrol 1995, 29:93\u201396.","journal-title":"Scand J Urol Nephrol"},{"key":"61_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","volume":"57","author":"IA Eland","year":"2001","unstructured":"Eland IA, Van Der Lei J, Stricker BHC, Sturkenboom MJCM: Incidence of priapism in the general population. Urology 2001, 57:970\u2013972.","journal-title":"Urology"},{"key":"61_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.ijir.3901018","volume":"15","author":"CM Earle","year":"2003","unstructured":"Earle CM, Stuckey BGA, Ching HL, Wisniewski ZS: The incidence and management of priapism in western Australia: a 16 year audit. Int J Impot Res 2003, 15:272\u2013276.","journal-title":"Int J Impot Res"},{"key":"61_CR10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","volume":"90","author":"AB Adeyoju","year":"2002","unstructured":"Adeyoju AB, Olujohungbe ABK, Morris J, et al.: Priapism in sickle cell disease; incidence, risk factors and complications - an international multicentre study. BJU Int 2002, 90:898\u2013902.","journal-title":"BJU Int"},{"key":"61_CR11","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1001\/archinte.140.11.1434","volume":"140","author":"AM Emond","year":"1980","unstructured":"Emond AM, Holman R, Hayes RJ, Serjeant GR: Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980, 140:1434\u20131437.","journal-title":"Arch Intern Med"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-5347(17)58497-9","volume":"117","author":"JH Nelson","year":"1977","unstructured":"Nelson JH, Winter CC: Priapism: evolution of management in 48 patients in a 22-year series. J Urol 1977, 117:455\u2013458.","journal-title":"J Urol"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1152\/physrev.1995.75.1.191","volume":"75","author":"KE Andersson","year":"1995","unstructured":"Andersson KE, Wagner G: Physiology of penile erection. Physiol Rev 1995, 75:191\u2013236.","journal-title":"Physiol Rev"},{"key":"61_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1056\/NEJM199201093260203","volume":"326","author":"J Rajfer","year":"1992","unstructured":"Rajfer J, Aronson WJ, Bush PA, et al.: Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992, 326:90\u201394.","journal-title":"N Engl J Med"},{"key":"61_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1126\/science.1378650","volume":"257","author":"AL Burnett","year":"1992","unstructured":"Burnett AL, Lowenstein CJ, Bredt DS, et al.: Nitric oxide: a physiologic mediator of penile erection. Science 1992, 257:401\u2013403.","journal-title":"Science"},{"key":"61_CR16","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1073\/pnas.052712499","volume":"99","author":"KJ Hurt","year":"2002","unstructured":"Hurt KJ, Musicki B, Palese MA, et al.: Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci U S A 2002, 99:4061\u20134066.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"61_CR17","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","volume":"83","author":"AP Somlyo","year":"2003","unstructured":"Somlyo AP, Somlyo AV: Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003, 83:1325\u20131358.","journal-title":"Physiol Rev"},{"key":"61_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/83258","volume":"7","author":"K Chitaley","year":"2001","unstructured":"Chitaley K, Wingard C J, Clinton Webb R, et al.: Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 2001, 7:119\u2013122.","journal-title":"Nat Med"},{"key":"61_CR19","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1097\/01.ju.0000065808.45445.a1","volume":"169","author":"R Takahashi","year":"2003","unstructured":"Takahashi R, Nishimura J, Hirano K, et al.: Modulation of Ca2+ sensitivity regulates contractility of rabbit corpus cavernosum smooth muscle. J Urol 2003, 169:2412\u20132415.","journal-title":"J Urol"},{"key":"61_CR20","doi-asserted-by":"publisher","first-page":"9121","DOI":"10.1073\/pnas.0400520101","volume":"101","author":"TJ Bivalacqua","year":"2004","unstructured":"Bivalacqua TJ, Champion HC, Usta MF, et al.: RhoA\/Rhokinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A 2004, 101:9121\u20139126.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/j.1939-4640.2003.tb02743.x","volume":"24","author":"TJ Bivalacqua","year":"2003","unstructured":"Bivalacqua TJ, Usta MF, Champion HC, et al.: Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003, 24(Suppl):S17-S37.","journal-title":"J Androl"},{"key":"61_CR22","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"TF Lue","year":"2000","unstructured":"Lue TF: Erectile dysfunction. N Engl J Med 2000, 342:1802\u20131813.","journal-title":"N Engl J Med"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-5347(17)34928-5","volume":"151","author":"GA Broderick","year":"1994","unstructured":"Broderick GA, Gordon D, Hypolite J, Levin RM: Anoxia and corporal smooth muscle dysfunction: mechanism for ischemic priapism. J Urol 1994, 151:259\u2013262.","journal-title":"J Urol"},{"key":"61_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S0022-5347(01)65258-3","volume":"157","author":"Tejada de Saenz","year":"1997","unstructured":"Saenz de Tejada I, Kim NN, Daley JT, et al.: Acidosis impairs rabbit trabecular smooth muscle contractility. J Urol 1997, 157:722\u2013726.","journal-title":"J Urol"},{"key":"61_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/sj.ijir.3901231","volume":"17","author":"A Muneer","year":"2005","unstructured":"Muneer A, Cellek S, Dogan A, et al.: Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Impot Res 2005, 17:10\u201318.","journal-title":"Int J Impot Res"},{"key":"61_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF01037931","volume":"25","author":"Y Evliyaoglu","year":"1997","unstructured":"Evliyaoglu Y, Kayrin L, Kaya B: Effect of pentoxifylline on veno-occlusive priapism-induced corporeal tissue lipid peroxidation in a rat model. Urol Res 1997, 25:143\u2013147.","journal-title":"Urol Res"},{"key":"61_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0090-4295(03)00484-9","volume":"62","author":"R Munarriz","year":"2003","unstructured":"Munarriz R, Park K, Huang YH, et al.: Reperfusion of ishcemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism. Urology 2003, 62:760\u2013764.","journal-title":"Urology"},{"key":"61_CR28","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0407183102","volume":"102","author":"HC Champion","year":"2005","unstructured":"Champion HC, Bivalacqua TJ, Takimoto E, et al.: Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A 2005, 102:1661\u20131666. First manuscript to describe potential pathogenic mechanism of priapsim.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"61_CR29","doi-asserted-by":"crossref","unstructured":"Bivalacqua TJ, Liu T, Musicki B, et al.: Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. Eur Urol 2006, In press.","DOI":"10.1016\/j.eururo.2006.10.061"},{"issue":"Suppl 5","key":"61_CR30","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1038\/sj.ijir.3901077","volume":"15","author":"AL Burnett","year":"2003","unstructured":"Burnett AL: Priapism pathophysiology: clues to prevention. Int J Impot Res. 2003, 15(Suppl 5):S80-S85.","journal-title":"Int J Impot Res"},{"key":"61_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1172\/JCI118107","volume":"96","author":"WA Border","year":"1995","unstructured":"Border WA, Noble NA: Fibrosis linked to TGF-beta in yet another disease. J Clin Invest 1995, 96:655\u2013656.","journal-title":"J Clin Invest"},{"key":"61_CR32","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI, Hassoba HM, Pillarisetty RJ, et al.: Peyronie\u2019s disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997, 158:1391\u20131394.","journal-title":"J Urol"},{"key":"61_CR33","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/00005392-199909010-00089","volume":"162","author":"A Nehra","year":"1999","unstructured":"Nehra A, Gettman MT, Nugent M, et al.: Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo. J Urol 1999, 162:910\u2013915.","journal-title":"J Urol"},{"key":"61_CR34","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0022-5347(01)67730-9","volume":"153","author":"RB Moreland","year":"1995","unstructured":"Moreland RB, Traish A, McMillin MA, et al.: PGE1 suppresses the induction of collagen synthesis by transforming growth factor-beta 1 in human corpus cavernosum smooth muscle. J Urol 1995, 153:826\u2013834.","journal-title":"J Urol"},{"key":"61_CR35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/j.1939-4640.2001.tb02207.x","volume":"22","author":"TJ Bivalacqua","year":"2001","unstructured":"Bivalacqua TJ, Champion HC, Leungwattanakij S, et al.:Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie\u2019s-like condition in the rat. J Androl 2001, 22:497\u2013506.","journal-title":"J Androl"},{"key":"61_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1478-3231.2004.0961.x","volume":"24","author":"WI Jeong","year":"2004","unstructured":"Jeong WI, Do SH, Yun HS, et al.: Hypoxia potentiates transforming growth factor-beta expression of hepatocyte during the cirrhotic condition in rat liver. Liver Int 2004, 24:658\u2013668.","journal-title":"Liver Int"},{"key":"61_CR37","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0022-5347(01)62307-3","volume":"160","author":"M Ul-Hasan","year":"1998","unstructured":"Ul-Hasan M, El-Sakka AI, Lee C, et al.: Expression of TGF-beta-1 mRNA and ultrastructural alterations in pharmacologically induced prolonged penile erection in a canine model. J Urol 1998, 160:2263\u20132266.","journal-title":"J Urol"},{"key":"61_CR38","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","volume":"170","author":"DK Montague","year":"2003","unstructured":"Montague DK, Jarow J, Broderick GA, et al.: Members of the erectile dysfunction guideline update panel: american urological association guideline on the management of priapism. J Urol 2003, 170:1318\u20131324.","journal-title":"J Urol"},{"key":"61_CR39","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/S0022-5347(18)33427-X","volume":"175","author":"TJ Bivalacqua","year":"2006","unstructured":"Bivalacqua TJ, Champion HC, Mason W, Burnett AL:Long-term phosphodiesterase type 5 inhibitor therapy reduces priapic activity in transgenic sickle cell mice. J Urol 2006, 175:A387.","journal-title":"J Urol"},{"key":"61_CR40","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","volume":"67","author":"AL Burnett","year":"2006","unstructured":"Burnett AL, Bivalacqua TJ, Champion HC, Musicki B:Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 2006, 67:1043\u20131048. First clinical evidence for the use of PDE5 inhibitor therapy for recurrent priapism.","journal-title":"Urology"},{"key":"61_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.ijir.3901261","volume":"16","author":"O Sanli","year":"2004","unstructured":"Sanli O, Armagan A, Kandirali E, et al.: TGF-beta1 neutralizing antibodies decrease the fibrotic effects of ischemic priapism. Int J Impot Res 2004, 16:492\u2013497.","journal-title":"Int J Impot Res"},{"key":"61_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1743-6109.2005.00090.x","volume":"3","author":"J Rajfer","year":"2006","unstructured":"Rajfer J, Gore JL, Kaufman J, Gonzalez-Cadavid N: Case Report: Avoidance of palpable corporal fibrosis due to priapism with upregulators of nitric oxide. J Sex Med 2006, 3:173\u2013176.","journal-title":"J Sex Med"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-006-0061-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0061-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T17:36:34Z","timestamp":1707932194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-006-0061-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s11934-006-0061-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732391110.793541080","asserted-by":"object"}]},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}